Five of six cases with biallelic RAD51B inactivation also harbored biallelic somatic variants in TP53, which are known to be strongly selected for in BRCA-associated HRD cancers18. The gene discussed is RAD51B; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.